Nicole Hadas

(Ms. Nicole Hadas)

Currently holds positions in Keryx Biopharmaceuticals Inc and Akebia Therapeutics Inc

Positions

Position Company Period
President, Secretary Keryx Biopharmaceuticals Inc Dec. 12, 2018 -
Senior Vice President, Chief Legal Officer, Corporate Secretary Akebia Therapeutics Inc Jan. 1, 2013 -
Nicole Hadas's trades of Akebia Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-14 2024-05-13
PS Planned sale
12,016 -1.8%
1.26
USD 15,140 		12,016 -1.8% 1.26 USD 15,140
2024-03-01 2024-02-29
S Sale
5,974 -0.9%
1.58
USD 9,439 		5,974 -0.9% 1.58 USD 9,439
2024-02-29 2024-02-27
PS Planned sale
7,411 -1.1%
1.52
USD 11,265 		7,411 -1.1% 1.52 USD 11,265
2023-05-25 2023-05-25
S Sale
63,186 -10.8%
1.22
USD 77,270 		63,186 -10.8% 1.22 USD 77,270
2023-03-03 2023-03-01
S Sale
1,088 -0.4%
0.88
USD 955 		1,088 -0.4% 0.88 USD 955
2023-03-03 2023-03-01
S Sale
6,613 -2.2%
0.88
USD 5,803 		6,613 -2.2% 0.88 USD 5,803
2023-03-03 2023-03-01
S Sale
5,333 -1.8%
0.88
USD 4,680 		5,333 -1.8% 0.88 USD 4,680
2023-03-01 2023-02-27
PS Planned sale
6,677 -2.2%
0.81
USD 5,430 		6,677 -2.2% 0.81 USD 5,430
2022-03-02 2022-03-01
PS Planned sale
1,078 -0.4%
2.17
USD 2,340 		1,078 -0.4% 2.17 USD 2,340
2022-03-02 2022-03-01
S Sale
6,556 -2.1%
2.17
USD 14,231 		6,556 -2.1% 2.17 USD 14,231
2022-03-02 2022-03-01
S Sale
6,873 -2.2%
2.17
USD 14,919 		6,873 -2.2% 2.17 USD 14,919
2022-03-02 2022-02-28
S Sale
6,555 -2.4%
2.15
USD 14,125 		6,555 -2.4% 2.15 USD 14,125
2021-04-01 2021-04-01
S Sale
1,060 -0.4%
3.40
USD 3,604 		1,060 -0.4% 3.40 USD 3,604
2021-03-02 2021-03-01
S Sale
7,976 -2.9%
3.40
USD 27,087 		7,976 -2.9% 3.40 USD 27,087
2021-03-02 2021-03-01
S Sale
6,309 -2.3%
3.40
USD 21,426 		6,309 -2.3% 3.40 USD 21,426
2020-03-02 2020-02-28
S Sale
7,050 -3.2%
8.70
USD 61,335 		7,050 -3.2% 8.70 USD 61,335
2017-10-04 2017-10-02
PS Planned sale
1,553 -1.4%
19.64
USD 30,501 		1,553 -1.4% 19.64 USD 30,501
2017-07-06 2017-07-03
PS Planned sale
1,554 -1.4%
14.26
USD 22,156 		1,554 -1.4% 14.26 USD 22,156
2017-04-04 2017-04-03
S Sale
1,556 -1.4%
9.18
USD 14,280 		1,556 -1.4% 9.18 USD 14,280
2017-01-03 2017-01-01
PS Planned sale
1,810 -2.1%
10.49
USD 18,988 		1,810 -2.1% 10.49 USD 18,988
2016-10-04 2016-10-01
S Sale
1,556 -1.8%
8.95
USD 13,934 		1,556 -1.8% 8.95 USD 13,934
2016-07-06 2016-07-05
PS Planned sale
1,557 -1.8%
7.47
USD 11,625 		1,557 -1.8% 7.47 USD 11,625
2016-04-05 2016-04-04
S Sale
1,556 -1.8%
9.41
USD 14,642 		1,556 -1.8% 9.41 USD 14,642
2016-01-06 2016-01-04
PS Planned sale
1,811 -2.7%
12.28
USD 22,239 		1,811 -2.7% 12.28 USD 22,239
// ... existing code ... // ... rest of the file ...